Banque Pictet & Cie’s Bio-Techne TECH Stock Holding History

Banque Pictet & Cie’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,760	Closed	-$1.64M	–	616
2022 Q4	$1.64M	Buy	+19,760	New	+$1.57M	0.02%	321

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Banque Pictet & Cie's TECH Position: Q1 2023 in Review

Banque Pictet & Cie sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 19,760 shares — an estimated $1.64M sold.

Banque Pictet & Cie first reported a position in TECH in Q4 2022 and held it in 1 quarter. The position peaked at $1.64M in Q4 2022. 549 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Banque Pictet & Cie reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
Banque Pictet & Cie sold 19,760 Bio-Techne shares in Q1 2023, an estimated $1.64M.
Banque Pictet & Cie first reported a position in Bio-Techne in Q4 2022 and held it in 1 quarter.
Banque Pictet & Cie's Bio-Techne position peaked at $1.64M in Q4 2022.
549 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Banque Pictet & Cie's 13F filing for Q1 2023, filed 1 May 2023.